Difference between revisions of "Uracil mustard"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapeutic" to "") |
m |
||
| Line 3: | Line 3: | ||
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
| + | |||
| + | ==Diseases for which it was used== | ||
| + | *[[Chronic lymphocytic leukemia - historical|Chronic lymphocytic leukemia]] | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| Line 15: | Line 18: | ||
[[Category:Alkylating agents]] | [[Category:Alkylating agents]] | ||
| + | |||
| + | [[Category:Chronic lymphocytic leukemia medications (historic)]] | ||
[[Category:FDA approved in 1962]] | [[Category:FDA approved in 1962]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
| + | [[Category:Stub]] | ||
Revision as of 02:00, 29 April 2022
General information
Class/mechanism: Alkylating agent
Route: PO
Extravasation: n/a
Diseases for which it was used
History of changes in FDA indication
- 9/13/1962: Initial FDA approval
Also known as
- Generic name: uramustine